Waxman asks drug and device firms for CME reports

Share this article:
US Rep. Henry Waxman (D-CA), head of the House Committee on Oversight and Government Reform, asked several drug and device firms for reports relating to CME, as part of a new off-label marketing probe he opened.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

 

Did you miss January's Top 40 Healthcare Transformers issue? Read how these inventors, strategists, entrepreneurs and wonks are challenging, disrupting and otherwise transforming the healthcare business. And join us April 30 to honor them at the Transforming Healthcare Dinner. Click here.